Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
Public ClinicalTrials.gov record NCT00307515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Controlled Evaluation of Fibrin Sealant 2 (FS2) as an Adjunct to Hemostasis for Soft Tissue Bleeding During Retroperitoneal or Intra-Abdominal Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.
Study identification
- NCT ID
- NCT00307515
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 135 participants
Conditions and interventions
Conditions
Interventions
Drug · Device
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Jan 9, 2009
2006
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Miami Research Associates | Miami | Florida | 33173 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| The Iowa Clinic | Des Moines | Iowa | 50309 | — |
| St. Agnes Healthcare, Inc. | Baltimore | Maryland | 21229 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| Mt. Sinai Hospital | New York | New York | 10029 | — |
| GYN Oncology Associates | Syracuse | New York | 13202 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Lehigh Valley Hospital | Allentown | Pennsylvania | 18103 | — |
| Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15206 | — |
| Lankenau Hospital | Wynnewood | Pennsylvania | 19096 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00307515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2009 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00307515 live on ClinicalTrials.gov.